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ABSTRACT  Cerebrum  and  cerebellum  contain  numerous  asymmetric synapses characterized  by the 
presence  of  a  postsynaptic  thickening  prominently  stained  by  phosphotungstic  acid  and  other 
electron-dense stains suitable for electron microscopy. A 51,000-Mr protein, copurified in postsynaptic 
density-enriched  fractions  from  cerebrum,  is  considered  to  be  a  well  established  marker  for  the 
postsynaptic density. On the basis of two criteria, our studies demonstrate that the 51,000-Mr protein 
marker  for  postsynaptic densities is virtually absent  in  cerebellum.  First, it is  present  in  negligible 
amounts in deoxycholate-insoluble fractions from cerebellum  but abundant in parallel  fractions from 
cerebrum.  Secondly,  the 51,000-Mr  protein, which  binds 12Sl-calmodulin  after SDS PAGE, is readily 
visualized in membrane samples from cerebrum  but is virtually undetectable in cerebellar samples. It 
is apparent that these results require reexamination of the role of the 51,000- Mr protein in postsynaptic 
density structures. 
Synapses in mammalian brain may be broadly classified into 
two general types based primarily upon morphological param- 
eters  of their  postsynaptic specializations.  One  type,  termed 
Gray's Type I or asymmetric synapses, are characterized by a 
30-rim separation of pre- and postsynaptic membranes and a 
pronounced accumulation of material on the cytoplasmic face 
of the postsynaptic membrane. This prominently stained struc- 
ture  is  termed  the  postsynaptic  density  (PSD)  and  is  only 
faintly  visible  in  Type  II or symmetrical synapses.  Type  II 
synapses  are  identified  in  the  electron  microscope,  not  by 
evident postsynaptic densities,  but by virtue of a uniform 20- 
nm separation of membranes together with an association of 
synaptic vesicles on one side (16). Quite often, Type II synaptic 
vesicles  are  somewhat  elongated  and  flattened  (32).  Such a 
classification scheme is too rigid to accommodate all synapses, 
and  it  is  apparent  that  these  characteristics  represent  major 
classes at either extreme of a continuum containing interme- 
diate PSD structures (10,  15). It is probable that any classifi- 
cation scheme based upon conventional morphological param- 
eters is likely to underestimate the variety of synaptic structures 
containing specific biochemical or functional attributes.  The 
identification of protein markers for various synaptic structures 
would greatly facilitate further classification of synapses. 
A widely accepted marker for the PSD structure is a protein 
with  a  Mr  of 51,000-52,000,  which  is  the  most  prominent 
protein  in  fractions enriched  in PSDs  (11,  20).  This  marker 
protein is generally assumed to reflect quantitatively the num- 
ber of PSD structures in isolated preparations.  As a point of 
reference, we will adopt the terminology of Kelly and Mont- 
gomery (19) in our discussions of the presence of this protein 
and refer to this protein as the major PSD protein (mPSDp). 
The  PSD  morphology is  remarkably  resistant  to  detergent 
action; Triton X-100, a nonionic detergent widely used during 
the preparation of PSD-enriched fractions, largely solubilizes 
membrane-bound proteins while leaving the PSD morphology 
apparently unaffected (9, 23). PSDs may be rendered resistant 
to stronger detergent  treatment  by the oxidizing agent, p-io- 
donitrotetrazolium  violet,  which  mediates  the  formation  of 
disulfide bonds between the mPSDp molecules (19, 21). Cross- 
linking the PSD, followed by extraction with the ionic deter- 
gent,  N-lauroyl-sarcosinate  (which  removes  the  majority  of 
proteins),  yields  a  crescent-shaped  structure  with  PSD-like 
morphology containing principally  the  mPSDp (l l,  20).  Si- 
multaneous purification of PSD-like structures and the mPSDp 
provides the major evidence that this protein is a constituent of 
the PSD, at least in cerebral tissue.  This correlation has been 
further verified by assessing the relative content of mPSDp in 
various cerebrum subcellular fractions.  Subcellular  fractions, 
known to contain synaptic structures, also contain the mPSDp; 
fractions enriched in myelin and mitochondria contain little of 
the mPSDp (19). 
An indication that the mPSDp may not be a universal PSD 
marker comes from the studies by Carlin et al.  (5) of a PSD- 
enriched fraction derived from canine cerebellum. Carlin et al. 
(5) used multistep velocity and gradient centrifugation proce- 
dures to prepare synaptosome-enriched fractions, followed by 
treatment with Triton X-100 and gradient centrifugation steps 
to prepare a PSD-enriched fraction. This procedure, originally 
designed to purify cerebral PSDs (9), yielded a cerebellar PSD- 
enriched  fraction  that  contained  little  mPSDp.  The  PSDs 
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derived from cerebrum by several morphological parameters. 
Cerebral,  but not cerebellar,  PSDs  contain a  central perfora- 
tion. Furthermore, instead of 20- to 30-rim aggregates observed 
in cerebral  PSDs,  cerebeUar PSDs contain  a latticelike  struc- 
ture.  The average cross-sectional thickness of cerebellar PSDs 
(33 nm) is thinner than that of cerebral PSDs (58 nm). On the 
basis  of the  above morphological  criteria,  these  investigators 
describe the PSD-enriched fraction from cerebellum as derived 
from Type II synapses, and PSDs from cerebrum, from Type 
I synapses (5). 
To  assess  the  possibility  that  a  subpopulation  of Type  I 
synapses containing the mPSDp does exist in the cerebellum, 
it  is  necessary  to  use  approaches  that  are  not  prone  to  the 
vagaries of a multistep fractionation scheme, where the distri- 
bution of synaptic structures  must be assessed in each subfrac- 
tion. We used two unique properties of the mPSDp to assess its 
presence  in  various  subcellular  fractions:  its  insolubility  in 
deoxycholate  (DOC)  and  its  calmodulin-binding  properties. 
Using these two criteria,  we have determined that the mPSDp 
is  virtually  absent  in  cerebellum.  These  observations require 
reconsideration of the role of the mPSDp in Type I synapses. 
MATERIALS AND  METHODS 
Preparation and Analysis of 5ubcellular Fractions 
The cerebrum and cerebellum were dissected taking care not to include brain 
stem tissue. Subeellular  fractions were prepared in parallel  from cerebellum, from 
a  mixture of cerebellum and cerebrum combined before homogenization, and 
from cerebrum.  The  three starting samples (from  150- to 200-g rats) were  16 
cerebellums (3.88 g wet weight), eight cerebellums and two cerebrums (1.91 and 
1.71 g, respectively), and four cerebrums (3.71 g). The synaptic plasma membrane 
(SPM) fractions were prepared from each starting sample as described by Jones 
and Matus (l  8) with the following  modifications: all sucrose solutions (expressed 
as wt/wt) were buffered with 5 mM HEPES, pH 7.4, and contained 50 pM CaCI~ 
(36). To increase yields, the initial nuclear pellets (P~) were rehomogenized and 
first and second supernatants ($1) combined (9). Each crude mitochondrial (P2) 
pellet (11,000  rpm  for  20  rain in  SorvaU  SS34;  DuPont  Instruments-Sorvall 
Biomedical Div., DuPont Co., Newtown, CT) was lysed by suspension in 9 ml of 
5 mM Tris-HCl, pH 8.1, containing 50,aM CaCI~ (36). After a 45 min incubation 
at 0°C, the sucrose concentration of each P2 was adjusted to 34% as described 
(14). SW 25.2 nitrocellulose tubes (Beckman Instruments Inc., Spinco Div., Palo 
Alto, CA) were loaded with 5 ml of 10% sucrose, 20 ml of 28.5% sucrose and 35 
ml of 34% sucrose containing the lysed P2 fractions and centrifuged for 18 h at 
20,000  rpm.  The  SPM  fraction  was  collected  from  the  28.5%/34%  sucrose 
interface and diluted three-fold with H20 and pelleted. Crude homogenate and 
$1 fractions (4-ml aliquots) were each diluted with  12 ml H20 plus 2 ml  1~ 
sucrose and pelleted (Beckman Ti60 for 45 min at 45,000  rpm) to yield respec- 
tively, the crude membrane and crude membrane without nuclei (Pz + 3) fractions. 
For preparation of the  DOC-insoluble fractions,  the  three  pellets from  each 
starting sample were resuspended  in  H~O,  adjusted  to  1 mg/ml and  diluted 
twofold to a final composition of 1% (wt/vol) sodium deoxycholate (Schwarz/ 
Mann Research Lab. (Spring Valley, NY) Cat No.  1346 Lot No. TI070), 10 mM 
Tris-HCl, pH  7.6,  50 ,aM  CaCI2,  1 mM phenylrnethylsulfonyl fluoride (freshly 
prepared),  and 0.5  mg/ml protein in a  total volume of 2 ml in Beckman No. 
338819  polyallomer tubes.  After incubation at 37°C  for  1 h,  the sample was 
diluted  by  addition  of  1  ml  H~O,  underlayered  with  0.1  ml  56%  sucrose, 
overlayered with  H20  to  the  3.5  ml  total tube  capacity and  centrifuged  in 
Beckman No. 350575 adapters at 30,000 rpm in the Ty35 rotor. The supernatam 
was aspirated to 0.8 ml and mixed with 2.4 ml H20 and centrifuged again as 
above  but  without the  sucrose underlayer.  The  pellet was  resuspended  in  a 
twofold concentrate of modified Laemmli sample buffer (17, 22) and electropho- 
resis  performed as described previously  (17). Assessment  of the relative proportion 
of protein bands was performed using an ACD-18 automated microdensitometer 
(Gelman Instrument Co., Ann Arbor, MI).  Peptide analysis of selected bands 
from the SDS polyaerylamide gels was performed as described previously (13, 
17). 
Visualization of Calmodulin-binding Proteins 
Calmodulln  was  obtained  from  Calbinehem  (Calbioehem-Behring Corp., 
American Hcechst Corp.,  San Diego, CA) and iodinatcd by a  lactoperoxidase 
method (7)  to a  specific activity of 50 to  125 `aCi/mol. SDS  PAGE and  1251- 
calmodulin (12SI-CaM) binding to the separated protein were performed exactly 
as described previously (7).  Control experiments with l0 mM EDTA added to 
the I~I-CaM incubation mixture were performed in parallel. After drying, the 
extent of 125I-CaM binding was visualized by autoradiography. To quantify the 
results, slices were cut from the dried gels and counted in a Beckman Biogamma 
lI scintillation counter (Beckman Instruments, Inc., Scientific Instruments Div., 
Irvine CA). 
RESULTS 
Electrophoretic Analysis of DOC- 
insoluble Fractions 
In confirmation of  a previous report (36), the DOe-insoluble 
fraction  from  cerebrum  contains  high  quantities  of tubulin 
(Fig.  1). Based upon densitometry, the Coomassie-Blue-stain- 
ing band ascribed to tubulin accounted for at least 20%-30% of 
FIGURE  1  SDS  PAGE  of  pro- 
tein  residue  after  solubiliza- 
tion  in  1%  sodium  deoxycho- 
late. Crude membranes (A,  B, 
and  Q, combined P2+3 (D,  E, 
and  F)  and  SPM  fractions  (G, 
H,  and  /)  were collected dur- 
ing  successive  stages  of  the 
subcellular  ffactionation  de- 
scribed in Materials and Meth- 
ods,  using  cerebellum  (A,  D, 
and  G), combined cerebellum 
and cerebrum ( B,  E, and  H) or 
cerebrum ( C,  F, and  I) starting 
material.  The  tissue  sample 
was extracted with  deoxycho- 
late  as described  in  Materials 
and  Methods,  and  the  equiv- 
alent  of  150  #g  of  protein 
(measured  before  extraction) 
subjected  to  electrophoresis 
and  stained  by  Coomassie 
Blue; in the case of  B,  E, and  H, an equivalent of 150 #g of cerebral protein was electrophoresed along with the cerebellar protein. With  the 
gel system employed in these studies, a-tubulin  is not resolved from fl-tubulin. 
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uble  fraction from cerebrum  is  the  presence  of a  51,000-Mr 
protein, migrating in a manner similar to the previously iden- 
tiffed prominent macromolecular component of PSD prepara- 
tions  from  cerebrum  (9,  20).  Earlier  analysis  of the  DOC- 
insoluble  fraction from cerebrum  (36)  had  failed  to identify 
this  protein  because  of its electrophoretic mobility is  almost 
identical to that of tubulin (54,000 Mr). 
CerebeUar  DOC-insoluble  fractions  contained  similar 
amounts  of tubulin  but  considerably  lower  amounts  of the 
51,000-M~ protein than observed in cerebral fractions. Densi- 
tometry measurements indicate that 3%, 4%, and 6.5% of the 
Coomassie  Blue  stain  is  present  in  the  51,000-M~  region  of 
DOC-insoluble material of, respectively the crude membrane, 
Pz÷3, and SPM fractions from cerebellum. For cerebrum,  16%, 
16% and  15% of the Coomassie Blue staining was ascribed to 
same respective fractions. 
Peptide Mapping of Major DOC- 
insoluble Proteins 
Peptide maps of the 54,000-Mr regions of the gels allowed 
verification that the proteins comigrating with tubulin stand- 
ards are indeed identical to tubulin  as purified  from cytosol 
(Figs.  2A,  B,  and  C).  The  51,000-Mr  protein  prominent  in 
DOC-insoluble fraction purified from cerebrum yielded eight 
major tryptic  x25I-labeled-peptides  (Fig.  2E);  of these,  seven 
were identical to published maps of the mPSDp (19).  There- 
fore, we conclude that the 51,000-M~ protein present in cerebral 
DOC-insoluble fractions is identical to the previously described 
mPSDp. In contrast, the peptide map of the 51,000-Mr region 
of the cerebellar sample does not contain significant amounts 
of the peptides characteristic of the mPSDp. In particular, the 
two peptides  indicated  by two arrows in the  cerebellar  map 
(Fig.  2D)  are  only  faintly  apparent--although  autoradi- 
ographic exposure time was increased twofold to enhance the 
detection of any minor mPSDp peptides present. The complex 
peptide mapping pattern of the cerebellar sample is indicative 
of a mixture of 51,000-Mr polypeptides. Control maps indicate 
little label incorporated into slices from blank polyacrylamide 
gel (Fig. 2 F). 
These results  strongly indicate  that the mPSDp associated 
with cerebrum PSDs is essentially absent from the cerebellum. 
However, another explanation is that the mPSDp exists in two 
forms. One form would be insoluble in DOC, while a  postu- 
lated second form would be soluble in the presence of deter- 
gents. If we further postulate that enzymatic activities present 
in cerebellum  (e.g.,  specific protease  or protein  phosphatase 
activities)  mediate  the  transformation  of detergent-insoluble 
into detergent-soluble  forms, then mixing of cerebellum  and 
cerebrum tissues before homogenization would be expected to 
decrease the content of mPSDp present in the DOC-insoluble 
samples.  In contradiction to this hypothesis, all three subcel- 
lular fractions derived from mixtures of cerebellum and cere- 
brum  tissue,  whether  crude  or  enriched  in  SPM  structures, 
contain virtually identical amounts of the mPSDp as the equiv- 
alent fractions from cerebrum (Fig. 1 B, C, E, F, H, and I). 
Detection  of rnPSDp by 12SI-CaM Binding 
A protein of 51,000 Mr has been reported to be a prominent 
calmodulin-binding protein (7).  Remarkably, the calmodulin- 
binding property of this protein is at least partially retained or 
renatured by removing SDS from gels. Visualization is accom- 
plished  by incubating  the  gel with  125I-CaM, washing  away 
unbound 125I-CaM, and autoradiography of the dried gel. This 
procedure provided visualization of IzsI-CaM-binding proteins 
in a complex mixture and is highly selective for a fraction of 
the protein species observed by Coomassie blue staining (Fig. 
3).  12~I-CaM binds  to  an  identical  pattern  of cerebral  SPM 
proteins as described by Carlin et al.  (7).  Since other proteins 
derived  from  mitochondria  or  glia  have  an  electrophoretic 
mobility near 51,000 Mr, it was necessary to verify that the 125I- 
CaM-binding protein observed in the cerebral DOC-insoluble 
fraction  is  identical  to  the  mPSDp.  Readily  detectable  125I- 
CaM binding to the mPSDp was observed even when < 1/~g of 
the  DOC-insoluble  residue  was  loaded  on  the  gels.  Precise 
alignment of the ~2~I-CaM-labeled  band and the mPSDp Coo- 
massie-Blue-staining band was observed. The mPSDp was the 
FIGURE  2  Autoradiographs of 
laSl-labeled  tryptic  peptides 
from 54,000-Mr and 51,000- Mr 
regions of SDS polyacrylamide 
gels. Gel  slices were obtained 
from  the  54,000-Mr  region of 
gels: peptide map A is from gel 
Fig. 1 D; peptide map B is from 
Fig. 1 F; peptide map C is from 
a gel of tubulin  standard pre- 
pared  from  rat  brain  cytoso[. 
The  following  peptide  maps 
were  from  the  51,000-Mr  re- 
gion  of  the  following  gels: 
peptide map  D  from  gel  1 D; 
peptide map  E is from Fig. 1 F. 
Peptide map  Fis from a blank 
region of the gel. Peptide maps 
were  exposed for 6  h,  except 
D,  20  h.  Electrophoresis  was 
performed  from  left  to  right, 
and  chromatography  from 
bottom to top. 
RAPID COMMUNICATIONS  745 most  prominent  125I-CaM-binding  protein  in  the  cerebral 
DOG-insoluble  fraction;  also  detected  were  significant  12sI- 
CaM-binding proteins of 61,000 and 224,000 Mr;  and fainter 
t25I-CaM-binding proteins at 32,000,  30,000,  and  143,000 Mr. 
On the basis of estimates of the mPSDp content of the cerebral 
DOC-insoluble  fraction  and  measurement  of the  amount  of 
125I-CaM bound, we estimate that 125I-CaM binds at a level less 
than one-tenth that calculated assuming a stoichiometry of one 
calmodulin bound to each mPSDp molecule. This is probably 
due to the limited access of calmodulin to the protein retained 
in the gel (7),  but it could also be due to incomplete renatur- 
ation  of the  mPSDp  calmodulin-binding  site.  The  cerebral 
SPM  fraction  also  contained  a  75,000-M,  125I-CaM-bhading 
protein not observed in the DOC-insoluble fraction. 12~I-CaM 
labeling  of the  30,000-  and  143,000-Mr  proteins  was  more 
pronounced in cerebral SPM than in cerebral DOG-insoluble 
fraction.  The total homogenate fraction from cerebrum con- 
tained in addition, a 24,000-M~ x25I-CaM-binding protein (Fig. 
3). Most of  the t25I-CaM-binding proteins observed in cerebrum 
were also observed in cerebellum with the notable exceptions 
of the  75,000-  and  51,000-M~  proteins,  indicating  that  little 
mPSDp is found in the cerebellum, x25I-CaM binding to crude 
homogenates  from  cerebellum  and  cerebrum  yielded  essen- 
tially the same results as when SPM fractions were analyzed. 
We investigated the binding profile of t25I-CaM  binding to 
the mPSDp fraction in cerebral and cerebellar SPM fractions 
as well as the DOG-insoluble fraction derived  from cerebral 
SPM.  As  previously  observed  (7),  ~25I-CaM binding  to  gel 
bands  is  not  linear  over  a  wide  range  of applied  protein. 
However, when the  gel slices  from gels loaded with <75 #g 
cerebellar  or  cerebrum  protein  or <5  #g  of DOC-insoluble 
protein are analyzed, the binding is approximately linear (Fig. 
4). The linear interval of  the isotherm corresponds to conditions 
where <20,000 cpm of ~25I-CaM is  bound per 51,000-M, gel 
slice.  Quantification of the level of mPSDp indicates the fol- 
lowing  calculated  slopes:  cerebral  DOC-insoluble  fraction, 
4,600 cpm//tg protein; cerebrum SPM, 220 cpm/#g; cerebellum 
SPM,  10 cpm/#g. When cerebral DOC-insoluble sample was 
diluted  with  50  or  75  #g  of cerebellar  SPM  protein  in  the 
Laemmli sample buffer, the slope was increased almost twofold 
to 8,500 cpm//~g (data not shown). This enhancement of the 
binding of ~25I-CaM in the presence of SDS denatured  cere- 
bellar proteins could be due to a carrier effect during dilution 
FIGURE  3  12SI-CaM overlay of SDS PAGE of crude membrane and 
synaptic  plasma  membrane fractions.  Gels  A-D, crude  homoge- 
hates; gels  E-H, synaptic plasma membrane fractions from cerebel- 
lum A, C, E, G, and cerebrum B, D, F, H. After binding~251-CaM and 
washing, the gels were stained with  Coomassie Blue  A,  B,  E,  F or 
autoradiographed Cand  D  (38#g, 20-h exposure); G and  H  (50/tg, 
6-h exposure). 
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FIGURE  4  Scintillation 
counting  of  51,000-M~  re- 
gion from gels loaded with 
various amounts  of  DOC- 
insoluble  and  SPM 
fractions.  The  indicated 
amounts  of  protein  were 
loaded onto gels and elec- 
trophoresis  and  1251-CaM 
overlay as described in Ma- 
terials  and  Methods.  Gel 
slices  from  the  51,000-Mr 
region were counted at an 
efficiency  of  75%.  (0) 
DOC-insoluble  fraction 
from  cerebrum  SPM.  (&) 
Cerebrum  SPM.  (Z~) Cere- 
bellar SPM. 
or  to  an  increase  in  the  gel  band  width  which  has  been 
correlated with the degree of ~2SI-CaM binding (7). Whatever 
the  cause  for  the  enhanced  12SI-CaM binding,  it  serves  to 
strengthen the conclusion that little mPSDp is present in the 
cerebellum. 
DISCUSSION 
To relate differences in the cerebellar and cerebral content of 
the mPSDp to its structural role in Type I and Type II synapses, 
it would be of value to estimate the relative proportions of the 
synaptic classes in the two tissues.  There are numerous reports 
referring to Type I synapses in both the cerebrum and cerebel- 
lum, (cf. references  15, 35).  In some cases the relative propor- 
tions of Type I and Type II synapses in the various identified 
regions have been reported.  For example,  95% of synapses in 
the cat cerebellar molecular layer have morphological charac- 
teristics  similar to those of  Type I synapses (33), consistent with 
the observation that a large number of synaptic contacts with 
the Purkinje cell spines are almost exclusively Type I. On the 
other  hand,  Type II synapses are  observed on the dendritic 
shafts of the Purkinje cell and on the bulbous enlargements of 
stellar  cell  dendrites  and  basket  cell  bodies.  Overall,  these 
observations convey the impression that Type I  synapses are 
very common in  the  cerebellum.  Ideally,  an  estimate  of the 
relative protein content of Type I  synapses in the two tissues 
would be most useful, so that the specific content of mPSDp 
could  be  related  directly  to  the  content  of Type  I  synaptic 
protein in the two tissues.  Such quantitative  data are,  unfor- 
tunately, not available. However, if we assume that the content 
of mPSDp  is  directly  proportional  to the  counts  of Type  I 
synapses in the two tissues,  then our data would imply that 
there  is  one-twentieth  the  number  of Type  I  synapses  in 
cerebellum as in cerebrum. This is inconsistent with the large 
body of cerebellar ultrastructural observations. 
This confusing situation could be remedied by assuming that 
the mPSDp is an authentic marker for Type I PSD structures 
present  in  the  cerebrum  but  rare  in  the  cerebellum.  If the 
mPSDp is, indeed,  a component of cerebral Type I synapses, 
then the fact that the mPSDp is virtually absent in cerebellum 
implies that cerebellar and cerebral Type I synapses must now 
be further delineated.  However, the evidence that the mPSDp 
is an authentic component of the PSD is based entirely upon 
the results of subcellular distribution studies (19, 20). Progress in determining the precise localization of the mPSDp has been 
hindered  by the  fact  that  the  mPSDp is  nonantigenic;  thus 
immunocytochemical localization studies have not been pos- 
sible. In addition to containing readily identified PSD profiles, 
preparations  of PSD  contain  the  so-called  subsynaptic  web 
structures and interwoven filaments, as well as -50% nonde- 
script PSD-like material (9). It is not possible to identify which 
PSD structural feature contains the mPSDp, nor is it possible 
to state that all of the PSD structures and PSD-like material 
contains the mPSDp. 
In addition to the mPSDp, other macromolecules have been 
proposed as PSD constituents (3, 9, 20, 26, 27). These include 
tubulin,  intermediate  filament subunits,  and actin.  Although 
tubulin has been localized to the PSD by immunocytochemical 
techniques (25,  26,  36),  recent evidence suggests that tubulin 
accumulates in the PSD during the postmortem period before 
homogenization, thus weakening the hypothesis that tubulin is 
an authentic component of the PSD (6). Intermediate filament 
proteins  are  generally  thought  to  be  contaminants  of PSD 
preparations (25).  The presence of actin in the PSD structure 
has been inferred on the basis of co-electrophoresis of pairs of 
molecular  species  upon  two-dimensional  gels  with  purified 
cytoplasmic actins. These comigrating proteins exhibited tryp- 
tic peptide maps very similar, if not identical, to those generated 
from authentic  actins (20,  27).  Actin is widely distributed  in 
the cytoplasm and appears, as well, in other cell organelles (28, 
31) so that it could not be used with any certainty as a marker 
of PSD structures in isolated fractions. Other functional com- 
ponents  such  as  Thy-1  antigen,  neurotransmitter  receptors, 
phosphodiesterases,  and other modulatory proteins have also 
been postulated  to be present  in the synapse; however, these 
components may exist in extrasynaptic regions as well (1, 4, 12, 
14,  29,  34).  Recently, an antigenic determinant  of 95,000 Mr 
has  been  proposed  as  a  rather  general  marker  for synaptic 
structures  (30).  Further  delineation  of this  protein's  role  in 
synaptic structures  must await  development  of monospecific 
antisera  or  monoclonal  antibodies  against  this  antigenic 
marker. Thus, no macromolecule can be considered, without 
reservation, to be an exclusive marker for the PSD. 
The cerebral DOC-insoluble fraction, is reportedly rich in a 
postjunctional lattice structure  (23, 24,  36) and is remarkably 
rich in tubulin. This is consistent with tubulin's localization to 
the postsynaptic density by immunocytochemical techniques 
(25, 26, 36). It is not possible to determine whether the mPSDp 
directly interacts with tubulin to form the cerebral DOC-insol- 
uble  fraction.  However,  it  is  possible  to  conclude  that  the 
mPSDp is not required to obtain significant quantities of  DOC- 
insoluble tubulin, at least from cerebellar tissue.  Further studies 
are required to assess the relationship of the putative underly- 
ing postjunctional lattice structure to the native postsynaptic 
density. 
The conclusions drawn  from 125I-CaM gel overlay experi- 
ments do not depend on any assertion that the binding of this 
probe  to  the  SDS  denatured  proteins  is  of any  particular 
biological significance. However, studies using azido-125I-CaM 
as a photoalTmity-labeling reagent for calmodulin-binding pro- 
teins (2), which can be used under nondenaturing conditions, 
yield a profile of cerebral calmodulin-binding proteins similar 
to that described here and earlier (7).  The 51,000-Mr protein 
that is the focus of this communication is apparently identical 
to the 57,000-Mr protein described by Andreasen et al. (2). The 
determination  of the  125I-CaM-binding protein  Mr  by cross- 
linking  experiments  may be subject  to nonsystematic errors. 
Should the mPSDp prove to be an authentic calmodulin bind- 
ing protein,  then  the  great difference  in  mPSDp content  in 
cerebellum and cerebrum should have implications for the role 
of calmodulin in cerebellar and cerebral synaptic structure and 
physiology.  It  should  be  noted  that  the  brain  and  muscle 
specific  Ca++-binding  protein,  parvalbumin,  is  localized  to 
neurons scattered  throughout the nervous system (8).  In the 
cerebellum, Purkinje cells were strongly labeled with an anti- 
parvalbumin antiserum, whereas no immunostaining was ob- 
served in the granular cell layer. Thus, the nonuniform distri- 
bution of the 51,000-Mr caimodulin-binding protein and par- 
valbumin may be indicative of unique Ca  ÷+ modulated meta- 
bolic pathways in various cerebellar and cerebral neurons. The 
striking degree of segregation of the mPSDp in cerebellum and 
cerebrum provides an opportunity for the elucidation  of the 
role of caimodulin  in synaptic structures,  by comparing the 
neurophysiological and ultrastructural  properties  of cerebral 
and cerebellar synapses. 
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